Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Golden Week For Daiichi: Damages Due From Ranbaxy Brothers

Executive Summary

In what seems like some consolation for Daiichi Sankyo after its disastrous acquisition of Ranbaxy Laboratories and subsequent divestment of the Indian company, arbitration proceedings in Singapore against the Singh brothers of Ranbaxy have gone the Japanese firm's way.


Related Content

Daiichi set for $3.6bn cash out of Sun
Daiichi initiates arbitration proceedings against Singhs of Ranbaxy but is it more symbolic?
Ranbaxy whistleblower pockets $50M+ in $500M settlement